CasNo.863127-77-9,Dasatinib monohydrate with high quality in stock CAS: 863127-77-9,(863127-77-9) Suppliers

1 Kilogram	FOB Price: USD 1000.0000

Min.Order :1 Kilogram
Purity: >99%
Payment Terms : L/C,D/A,D/P,T/T,

Keywords

863127-77-9 Dasatinib monohydrate high quality Dasatinib monohydrate

Quick Details

Appearance:White or almost white powder
Application:For lab research use only
PackAge:1kg/ bag, 25kg/drum
ProductionCapacity:10|Kilogram|Month
Storage:Keep in a cool & dry place
Transportation:By air/sea

Superiority:

opbatt Chemical Co. Ltd., Established in 2019, located in Shenzhen, Guangdong Province, is a Manufacturer and Trading company which specialized in fine chemicals like Pharmaceutical Reference Standards, Stable Isotopes, APIs and Intermediates. Our Stable Isotopes product line including 2H Labelled APIs, Reagents and Intermediates, 13C Labelled Substance, 15N Labelled Substance and 18O Labelled Substance.

We own a number of Senior pharmaceutical synthetic engineer, analysis engineer and analytical testing instrument. It make us have more than 1700 varieties compouds with high purity in stock in a short time.

We can provide you not only stock items, but also Custom Synthesis Service.

All of our Reference Standards, Stable Isotopes with COA, HPLC/GC, HNMR, qNMR, MS Spectrum.

Contact us at 0086-18923794376 or email us at yehh@topbatt.net, 24/7 stand by for you.

After-sales issues will be settled in 24 hours.

Details:

Product Name: Dasatinib monohydrate

Chemical Name: N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate

Molecular Formula: C22H28ClN7O3S

Molecular Weight: 488.01

CAS#: 863127-77-9

Packing: 1kg/ bag, 25kg/drum

Assay: >99%

Appearence: Off-White Powder

Price: Negotiable

Available Document: COA, MSDS, TSE/BSE, NMR, HPLC, DMF

Payment Term: T/T, L/C, O/A, ect.

Shipment: Package will dispatched in 7-15 days(According to the date of payment) by air.

Trade Term: EXW, FOB, CFR, DDU, DDP, ect.

Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML). The main targets of Dasatinib, are BCRABL, SRC, Ephrins and GFR.